Literature DB >> 17391351

Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.

S Dittmann1, F Seemüller, M J Schwarz, N Kleindienst, R Stampfer, J Zach, C Born, B Bernhard, K Fast, H Grunze, R R Engel, E Severus.   

Abstract

OBJECTIVES: Elevated homocysteine (Hcy) levels have been demonstrated to have a negative impact on cognitive functioning in healthy elderly people. Further studies suggest that they are an independent risk factor for dementia, in particular for Alzheimer's disease. Bipolar disorder is also associated with cognitive impairment. However, the pathophysiological mechanisms of these deficits have not been elucidated yet. This study examines the role of Hcy on cognition and its impact on psychosocial functioning in euthymic bipolar patients.
METHODS: A total of 55 euthymic bipolar patients and 17 healthy controls were enrolled in the study. Neuropsychological assessments consisted of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Trail Making Test (TMT), the Weschler Adult Intelligence Scale, 3(rd) edition (WAIS-III) subtest Letter-Number Sequencing Test (LNST) and the HAWIE-R (German version of the WAIS-R) subtest Information. Psychosocial functioning was assessed using the Social Adjustment Scale (SAS). To obtain plasma levels of Hcy, blood samples were collected in EDTA tubes, immediately put on ice, centrifuged within 15 min and stored at -80 degrees C. Total Hcy concentration was measured using high-performance liquid chromatography.
RESULTS: In the neuropsychological tests, patients differed significantly from healthy controls on the TMT B and the RBANS composite indices Language, Attention and Total Score. No differences were found on the HAWIE-R subtest Information, the TMT A, LNST or the RBANS composite indices Immediate Memory, Visuospatial/Constructional Abilities and Delayed Memory. Mean Hcy levels were 9.8 +/- 3.2 microm/L in the patient group and 7.8 +/- 2.1 microm/L in the control group, respectively (p = 0.012). In the patient group Hcy levels significantly correlated with gender, diagnosis and RBANS index scores for Immediate Memory, Language, Attention and Total Score. Linear regression analyses revealed a significant and independent association of Hcy levels with Immediate Memory and TMT B scores in the patient group. Homocysteine levels did not correlate with any measure in the control group. Spearman's correlations indicated that psychosocial functioning in bipolar patients is not associated with clinical variables apart from time in remission. However, it correlated significantly with working memory measures (LNST). No relationship could be determined between psychosocial functioning and Hcy plasma levels.
CONCLUSIONS: Elevated Hcy levels seem to be associated with cognitive impairment in euthymic bipolar patients, but not with psychosocial functioning. More studies are needed to clarify the role of Hcy in cognition in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391351     DOI: 10.1111/j.1399-5618.2007.00412.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  13 in total

1.  Factors associated with functional recovery in bipolar disorder patients.

Authors:  Aliza P Wingo; Ross J Baldessarini; Paul E Holtzheimer; Philip D Harvey
Journal:  Bipolar Disord       Date:  2010-05       Impact factor: 6.744

2.  Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder.

Authors:  Colin A Depp; Brent T Mausbach; Alexandrea L Harmell; Gauri N Savla; Christopher R Bowie; Philip D Harvey; Thomas L Patterson
Journal:  Bipolar Disord       Date:  2012-05       Impact factor: 6.744

3.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

4.  Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.

Authors:  Chengwu Yang; Elizabeth Garrett-Mayer; Jay S Schneider; Stephen M Gollomp; Barbara C Tilley
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

5.  RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms.

Authors:  Thilo Deckersbach; Andrew A Nierenberg; Ronald Kessler; Hannah G Lund; Rebecca M Ametrano; Gary Sachs; Scott L Rauch; Darin Dougherty
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

6.  The association between diagnosis, treatment delay and outcome among patients with Bipolar disorders.

Authors:  Igor Oyffe; Rachel Shwizer; Tali Stolovy
Journal:  Psychiatr Q       Date:  2015-03

7.  Functional remediation for bipolar disorder.

Authors:  Anabel Martínez-Arán; Carla Torrent; Brisa Solé; C Mar Bonnín; Adriane R Rosa; José Sánchez-Moreno; Eduard Vieta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-06-06

8.  Reliability and validity of the Repeatable Battery for the Assessment of Neuropsychological Status in community-dwelling elderly.

Authors:  Yan Cheng; Wenyuan Wu; Jiaqi Wang; Wei Feng; Xiangwei Wu; Chunbo Li
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

9.  Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer's disease.

Authors:  Hyun Kim; Kang Joon Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-03       Impact factor: 2.570

Review 10.  Homocysteine levels in schizophrenia and affective disorders-focus on cognition.

Authors:  Ahmed A Moustafa; Doaa H Hewedi; Abeer M Eissa; Dorota Frydecka; Błażej Misiak
Journal:  Front Behav Neurosci       Date:  2014-10-06       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.